BVS FY 2020 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$321M-5.6% YoY

Gross Profit

$234M72.7% margin

Operating Income

$21M6.6% margin

Net Income

$16M5.1% margin

EPS (Diluted)

$0.44

Cash Flow

Operating Cash Flow

$72M

Free Cash Flow

$51M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$494M

Total Liabilities

$350M

Stockholders' Equity

$142M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$321M	$340M	-5.6%
Gross Profit	$234M	$249M	-6.3%
Operating Income	$21M	$31M	-31.9%
Net Income	$16M	$7M	+139.5%